Scorpion Therapeutics, Inc.
Records under this name other than the patents Scorpion Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Scorpion Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 18/027,316 | Pyrrolo[3,2-c]pyridin-4-one Derivatives Useful in the Treatment of Cancer now held by Antares Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/030,211 | Heterocyclic Inhibitors of Egfr And/Or HER2, for Use in the Treatment of Cancer now held by Antares Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/293,823 | Compounds That Inhibit PI3K Isoform Alpha and Methods for Treating Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/568,899 | Urea Derivatives Which Can Be Used to Treat Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/849,887 | Methods of Synthesizing Egfr Inhibitors now held by Antares Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/100,051 | PI3K-ALPHA Inhibitors for the Treatment of Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/118,135 | Methods for Treating Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/120,060 | Indolizine Derivatives for Treating Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/121,282 | Methods for Treating Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/125,531 | Combination Therapy for Treating Cancer Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |